Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
Endogenex™ Announces $88 Million Series C Financing to Complete Pivotal Trial of the ReCET™ System in Patients with Type 2 Diabetes
